美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

HORIZON KINETICS MEDICAL ETF

35.29

+0.33190.95%

盤後：35.300.0109+0.03%16:10 EDT

成交量：227

成交額：8,052

市值：1,658.40萬

市盈率：- -

高：35.30

開：35.30

低：35.29

收：34.96

52周最高：37.90

52周最低：28.87

股本：46.99萬

流通股本：46.99萬

量比：0.09

換手率：0.05%

股息：0.41

股息率：1.16%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

三諾生物：取得醫療器械註冊證及註冊變更文件

繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗

榮昌生物：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告

证券日报网

安圖生物：公司及子公司獲得四項醫療器械註冊證

艾迪藥業：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告

证券日报网

諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影

轉型陣痛的昂利康：傳統業務增長失速，豪賭創新藥前景未明

諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。

諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力

一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」

諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。

諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標

麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航

山東省寧陽縣市場監管局開展醫療器械專項現場檢查

中国质量新闻网

我國首款AI輔助創新藥獲批上市，機構扎堆關注12只概念股

又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？

從美妝到生物科技公司植物醫生挺進大健康領域

高瓴重倉的醫療器械公司，IPO首日開盤跌超30%

創新藥概念震盪反彈德展健康3天2板

港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/MEDX/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.2891,"timestamp":1789416000000,"preClose":34.9572,"halted":0,"volume":227,"hourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"delay":0,"changeRate":0.009494467520281871,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"未開盤","change":0.3319,"latestTime":"09-14 16:00:00 EDT","open":35.3,"high":35.3,"low":35.2891,"amount":8052,"amplitude":0.000312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9572,"sharesOutstanding":569946,"nav":34.94,"aum":16419913.24,"dividendRate":0.01159,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"volumeRatio":0.087916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.087916,"shares":469946,"dividePrice":0.409,"high":35.3,"amplitude":0.000312,"preClose":34.9572,"low":35.2891,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.2891,"eps":0,"divideRate":0.01159,"volume":227,"delay":0,"ttmEps":0,"open":35.3,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":36.6906,"twentyDayClose":35.6938,"sixtyDayClose":34.2263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665231964","title":"三諾生物：取得醫療器械註冊證及註冊變更文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2665231964","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665231964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:24","pubTimestamp":1788780275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","IEIH","HART","GDOC","AGNG","MEDX","RSPH","LGHT","LNGR","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665831989","title":"繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665831989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665831989?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:10","pubTimestamp":1788779458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","BK4585","BK4532","PPH","IE00B4R5TH58.HKD","PSYK","LU0211331839.USD","IE0009355771.USD","LU0070302665.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","NVS","BK4578","IE00BJT1NW94.SGD","BMED","IE0002141913.USD","LU0208291251.USD","MDTX","IBBQ","BK4588","BGIA","IE00B2B36J28.USD","BK4007","IBBJ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731933","title":"榮昌生物：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731933","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731933?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:43","pubTimestamp":1788777780,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日，荣昌生物发布公告称，公司计划于2026年9月16日15：00-17：00参加2026年半年度科创板创新药行业集体业绩说明会，就投资者关心的问题进行交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxs9619866.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxs9619866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","LU1064131003.USD","BK0239","BK1583","IBBQ","BK1161","LU2148510915.USD","LU1969619763.USD","BK1574","159992","KSTR","LU2328871848.SGD","06978","LU1064130708.USD","688331","09995","MEDX","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315638","title":"安圖生物：公司及子公司獲得四項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:03","pubTimestamp":1788775426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","AGNG","GDOC","IEIH","LNGR","RSPH","HART","MEDX","MDEV","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319730","title":"艾迪藥業：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319730","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319730?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:01","pubTimestamp":1788775260,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日，艾迪药业发布公告称，公司计划于2026年9月16日15：00-17：00参与由上海证券交易所主办的科创板2026年半年度创新药行业集体业绩说明会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxw5472550.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxw5472550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1574","IBBQ","BK1161","688488","MEDX","159992","KSTR","06978","BK0262"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","LU1988902786.USD","MEDX","THNR","LLY","AGNG","IBB","WDNA","LLII","LU2324357040.USD","IXJ","FHLC","MHIP","BK4581","LU1551013425.SGD","IBBQ","ELIL","IYH","BK4588","LLYZ","BIB","PPH","OZEM","RXL","VHT","PBE","ELIS","AMGN","IHE","NAMS","TBXU","BBH","FTXH","LLYX","LU2746668974.SGD","MEDI","CURE","CANC","GDOC","XLV","LU0096364046.USD","IE00BK4W5L77.USD","TMED","TRUH","LU0456855351.SGD","PJP","JDOC","HRTS","SLN","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665904373","title":"轉型陣痛的昂利康：傳統業務增長失速，豪賭創新藥前景未明","url":"https://stock-news.laohu8.com/highlight/detail?id=2665904373","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665904373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:08","pubTimestamp":1788768480,"startTime":"0","endTime":"0","summary":"证券之星注意到，2026年上半年，昂利康营收、净利双双下滑逾10%，传统业务中原料药收入持续缩水，特色中间体规模更是“腰斩”，成为主要拖累。传统业务增长失速、创新业务远水难解，昂利康能否在多重压力中突围，仍有待时间检验。昂利康提示风险称，肿瘤创新药产品各阶段的成功率相对于其他创新药低，风险较高，不确定性较大。昂利康如何在传统业务与创新药漫长培育期之间找到平衡，才是市场关注的焦点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-09-07/doc-iniqyvry5536300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","MEDX","IBBQ","BK0239","159992","LNGR","BK1161","BK1574","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397441","title":"諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397441","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397441?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:42","pubTimestamp":1788766955,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0320765489.SGD","IE0009355771.USD","LU0070302665.USD","BK4007","IE00BJT1NW94.SGD","BK4532","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0211331839.USD","LU0208291251.USD","BK4585","MEDX","NVS","BK4578","BK4588","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739206","title":"諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739206","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:24","pubTimestamp":1788765896,"startTime":"0","endTime":"0","summary":"诺华股价下跌，因一项胆固醇药物研究失败加剧了研发管线压力路透伦敦9月7日-诺华公司的股价周一早盘下跌3.3%，此前该公司的一款降胆固醇药物在一项备受关注的研究中未能达到预期效果，这使得该疗法再次受到质疑，同时也提高了这家瑞士制药商即将公布的基因疗法数据所面临的压力。上周五晚间，诺华表示，在其针对高Lp 患者进行的一项大型晚期研究中，其药物佩拉卡森  未能降低心脏病发作和中风的风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE0002141913.USD","LU0208291251.USD","PPH","BK4578","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0211331839.USD","LU0320765489.SGD","NVS","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4585","IE00B4R5TH58.HKD","BK4532","BK4007","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BIB","LU0058720904.USD","IE0009355771.USD","BK4533","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4007","LU1057294990.SGD","MEDX","LU2242652126.USD","SG9999001440.SGD","BK4599","LU0070302665.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0889565916.HKD","LU0211331839.USD","LU2089984988.USD","LU1061106388.HKD","AMGN","BK4532","BK4139","LU2242646821.SGD","BK4585","LU2112291526.USD","LU0320765489.SGD","TBXU","IE00B2B36J28.USD","LU0122379950.USD","BK4566","IE00B4R5TH58.HKD","LU1571399168.USD","LU2468319806.SGD","PBE","LU0320765992.SGD","IBBQ","BK4588","LU0289739699.SGD","LU0868494617.USD","NVS","PPH","PJP","LU1023059063.AUD","BK4581","IBB","BK4534","BK4578","IE0002141913.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394493","title":"諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394493","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394493?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:30","pubTimestamp":1788762634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","BK4009","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","BK4585","IE0002141913.USD","MEDX","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4007","LU0208291251.USD","NVS","BAOS","PPH","IE00B2B36J28.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4588","LU0070302665.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394397","title":"諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394397?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:11","pubTimestamp":1788761471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","BK4533","LU0122379950.USD","LU0306806265.USD","LU1066051498.USD","SG9999011175.SGD","SG9999002232.USD","SG9999001176.SGD","LU1023059063.AUD","OZEM","BK4581","BK4588","LU1883839398.USD","BK4585","LU0225284248.USD","BK4592","LU0985481810.HKD","PFE","IE00BLSP4452.SGD","BK4578","BK4550","IE00B19Z3581.USD","LU0170899867.USD","LU0211331839.USD","LU1894683264.USD","LU1894683348.USD","IE0002141913.USD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU0321505439.SGD","LU2596442595.SGD","LU0289739699.SGD","SG9999003800.SGD","IE00B2B36J28.USD","BK4599","SG9999002224.SGD","IE0002270589.USD","BK4568","LU0208291251.USD","IE00BBT3K403.USD","LU0070302665.USD","LU0234572021.USD","LU0058720904.USD","LU1057294990.SGD","IE00B3T34201.USD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","MEDX","BK4534","SGXZ57979304.SGD","PPH","SG9999001176.USD","LU0225771236.USD","LU1066053197.SGD","LU0321505868.SGD","BK4532","IE0009355771.USD","LU0320765489.SGD","NVS","LU0306807586.USD","LU0456855351.SGD","LU0868494617.USD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665945893","title":"麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航","url":"https://stock-news.laohu8.com/highlight/detail?id=2665945893","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665945893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:10","pubTimestamp":1788761405,"startTime":"0","endTime":"0","summary":"麦科田通过多赛道布局、全球化运营、持续并购整合，构建一个抗周期、可持续的医疗器械平台。","market":"sg","thumbnail":"https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6537932","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02041","HEXmain","IEIH","BK1100","MDEV","MEDX","159883","GDOC","LNGR","BK1574","PTH","RSPH","AGNG","LGHT","09996","BK1583","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399937","title":"山東省寧陽縣市場監管局開展醫療器械專項現場檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399937","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399937?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:37","pubTimestamp":1788755820,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 9月7日，山东省宁阳县市场监管局执法人员深入辖区零售药店，开展医疗器械专项现场检查。执法人员重点查看血压计等二类医疗器械，仔细核对产品注册资料、进货票据，查验产品有效期、包装标识，排查有无过期失效、来路不明产品等风险隐患。检查过程坚持监管和指导同步开展，现场向药店从业人员讲解医疗器械经营相关规定，指出经营中的不足，督促经营者落实主体责任，规范进货查验和日常自查工作。下一步，该局将持续加大医疗器械监管频次，紧盯零售药店经营风险，切实保障群众用械安全。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-07/doc-iniqykzy9680694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","MEDX","RSPH","GDOC","PTH","LNGR","BK1583","BK1100","09996","159883","HART","LGHT","AGNG","MDEV","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665628399","title":"我國首款AI輔助創新藥獲批上市，機構扎堆關注12只概念股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665628399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665628399?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:35","pubTimestamp":1788755705,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","QTOC","IPOS","LNGR","IBBQ","CHAT","AGIX","AIPO","ARTY","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399350","title":"又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399350?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:07","pubTimestamp":1788754034,"startTime":"0","endTime":"0","summary":"随着多家医疗器械企业中报密集披露，医疗器械板块整体修复态势明确，业绩端已出现向上拐点。9月7日，麦科田正式于港交所挂牌上市，这意味着港股医疗器械板块再添一家平台型龙头。据多家权威机构测算，2026年全球医疗器械市场规模预计在6000亿至8000亿美元之间，并有望于2035年突破万亿美元大关。整体来看，麦科田此次登陆港股，业绩方面盈利拐点已经确认，商业化路径成熟，平台型的全面产品组合和全","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","AGNG","BK1583","BK1100","KCAI","RSPH","159883","MEDX","VXUS","PTH","GDOC","LNGR","02041","BK4588","LGHT","HART","IEIH","BK4585","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665962333","title":"從美妝到生物科技公司 植物醫生挺進大健康領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2665962333","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665962333?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:46","pubTimestamp":1788752760,"startTime":"0","endTime":"0","summary":"渠道红利退去、流量成本攀升、产品同质化加剧……中国美妆行业正经历从“快车道”到“窄门”的残酷转型。当“一招鲜”的战术红利消失，建立底层技术壁垒不再是可选项，而是生存项。当全行业 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDX","LNGR","BK4585","SYNB","IEIH","XBI","IBBJ","HBImain","BK4588","GDOC","AGNG","159837","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GDOC","LNGR","IEIH","REDS","BK1574","MEDX","MDEV","BK1583","BK4127","PTH","RSPH","159883","FRHC","AGNG","09996","HART","KCE","LGHT","IPOS","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665895395","title":"創新藥概念震盪反彈 德展健康3天2板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665895395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665895395?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:15","pubTimestamp":1788747304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665836774","title":"港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665836774","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665836774?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 06:53","pubTimestamp":1788735233,"startTime":"0","endTime":"0","summary":"西湖大学生命科学学院教授黄晶表示，AI辅助新药研发已不止于概念，而真正可以支撑原创药物从发现走向临床，直至上市。艾普司韦是西湖大学首款完全自主研发的1类创新药，用于成人轻型、中型新型冠状病毒感染的治疗。中国AI制药市场规模2025年已突破6亿元。从经营数据来看，AI相关业务正成为部分企业订单和收入增长的重要驱动力；与此同时，下游药企也在积极拥抱AI，研发提效成果逐步显现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","BK1574","BK4588","ARTY","BK1617","02196","BK1515","IBBQ","CHAT","BK4585","BK1191","BK1593","06978","159992","BK1161","02228","AIPO","03696","MEDX","BK1141","KCAI","VTHR","QTOC","LNGR","VXUS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":8,"totalSize":242,"code":"91000000","status":"200"}]}}